---
schema_version: "secwatch.filing_event.v1"
accession: "0000885590-21-000047"
form_type: "8-K"
ticker: "BHC"
cik: "0000885590"
company_name: "Bausch Health Companies Inc."
filed_at: "2021-09-30T23:59:59+00:00"
generated_at: "2026-06-29T00:33:09.154593+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bausch Health names Seana Carson as General Counsel effective Bausch + Lomb IPO closing

## Summary
- Christina Ackermann will become General Counsel of Bausch + Lomb upon IPO closing.
- Joseph Gordon transfers to Bausch + Lomb to lead global consumer, vision care, surgical and EMEA pharma.
- Seana Carson appointed General Counsel of Bausch Health, effective IPO closing.
- Seana Carson base salary CA$665,000; cash incentive 60% of base; US$250,000 RSU grant.
- Changes part of previously announced separation of Bausch + Lomb via IPO.

## SEC filing metadata
- accession: 0000885590-21-000047
- form_type: 8-K
- ticker: BHC
- cik: 0000885590
- company_name: Bausch Health Companies Inc.
- filed_at: 2021-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/0000885590-21-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/bhc-20210923.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885590-21-000047
- JSON: https://secwatch.observer/filing/0000885590-21-000047.json
- Plain text: https://secwatch.observer/filing/0000885590-21-000047.txt

## Key facts
- Executive change
  Seana Carson was appointed as General Counsel at Bausch Health Companies Inc..
  - Action: appointed
  - Role: General Counsel
  source text: In connection with Christina Ackermann’s Bausch + Lomb appointment, Seana Carson, Senior Vice President of Legal, will be appointed General Counsel of Bausch Health, effective as of the IPO Closing Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/0000885590-21-000047-index.htm
- Executive change
  Joseph Gordon departed as other_named_officer at Bausch Health Companies Inc..
  - Action: will transfer
  source text: Joseph Gordon will also transfer with Bausch + Lomb, effective as of the IPO Closing Date, where he will lead Bausch + Lomb’s global consumer, vision care and surgical businesses as well as the EMEA ophthalmology pharmaceutical business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/0000885590-21-000047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.